Published Papers & Misc - TORII Satoru

Division display  41 - 47 of about 47 ／  All the affair displays >>

  1. Ken-ichi Yasumoto, Yusuke Kowata, Atsushi Yoshida, Satoru Torii, Kazuhiro Sogawa. Role of the intracellular localization of HIF-prolyl hydroxylases. Biochimica et Biophysica Acta -Molecular Cell Research. 2009.05; 1793 (5): 792-797. ( PubMed, DOI )

  2. Satoru Torii, Takuya Yamamoto, Yoshiki Tsuchiya, Eisuke Nishida. ERK MAP kinase in G cell cycle progression and cancer. Cancer Science. 2006.08; 97 (8): 697-702. ( PubMed, DOI )

  3. Kunio Kondoh, Satoru Torii, Eisuke Nishida. Control of MAP kinase signaling to the nucleus. Chromosoma. 2005.07; 114 (2): 86-91. ( PubMed, DOI )

  4. Satoru Torii, Kei Nakayama, Takuya Yamamoto, Eisuke Nishida. Regulatory mechanisms and function of ERK MAP kinases. Journal of Biochemistry. 2004.11; 136 (5): 557-561. ( PubMed, DOI )

  5. Satoru Torii, Morioh Kusakabe, Takuya Yamamoto, Momoko Maekawa, Eisuke Nishida. Sef is a spatial regulator for Ras/MAP kinase signaling. Developmental Cell. 2004.07; 7 (1): 33-44. ( PubMed, DOI )

  6. Hiroshi Hanafusa, Satoru Torii, Takayuki Yasunaga, Kunihiro Matsumoto, Eisuke Nishida. Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty. Journal of Biological Chemistry. 2004.05; 279 (22): 22992-22995. ( PubMed, DOI )

  7. Hiroshi Hanafusa, Satoru Torii, Takayuki Yasunaga, Eisuke Nishida. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nature Cell Biology. 2002.11; 4 (11): 850-858. ( PubMed, DOI )

< PREV - NEXT >

To the head of this page.▲